The natural history of aberrant crypt foci.

[1]  T. P. Pretlow,et al.  Aberrant crypt foci: what we know and what we need to know. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  M. Miyazaki,et al.  Assessment of Rectal Aberrant Crypt Foci by Standard Chromoscopy and its Predictive Value for Colonic Advanced Neoplasms , 2006, The American Journal of Gastroenterology.

[3]  J. Gohagan,et al.  Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. , 2005, Journal of the National Cancer Institute.

[4]  S. Cross,et al.  Rectal Aberrant Crypt Foci Identified Using High-Magnification-Chromoscopic Colonoscopy: Biomarkers for Flat and Depressed Neoplasia , 2005, The American Journal of Gastroenterology.

[5]  Christopher J Gostout,et al.  Endoscopic identification and quantification of aberrant crypt foci in the human colon. , 2002, Gastrointestinal endoscopy.

[6]  Denis E. Corpet,et al.  Most Effective Colon Cancer Chemopreventive Agents in Rats: A Systematic Review of Aberrant Crypt Foci and Tumor Data, Ranked by Potency , 2002, Nutrition and cancer.

[7]  P C Prorok,et al.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. , 2000, Controlled clinical trials.

[8]  C. Fenoglio-Preiser,et al.  Review Article: Aberrant Crypt Foci: A Review , 1999 .

[9]  Junji Kato,et al.  Aberrant crypt foci of the colon as precursors of adenoma and cancer , 1998, The New England journal of medicine.

[10]  S. Yoshida,et al.  Detection of aberrant crypt foci by magnifying colonoscopy. , 1997, Gastrointestinal endoscopy.

[11]  H. Esumi,et al.  Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. , 1995, Gastroenterology.

[12]  S. Gallinger,et al.  K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. , 1993, Carcinogenesis.

[13]  S. Minkin,et al.  Promotion of aberrant crypt foci and cancer in rat colon by thermolyzed protein. , 1992, Journal of the National Cancer Institute.

[14]  L. Roncucci,et al.  Classification of aberrant crypt foci and microadenomas in human colon. , 1991, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  R. Bird,et al.  Effect of disulfiram on 1,2-dimethylhydrazine- and azoxymethane-induced aberrant crypt foci. , 1991, Carcinogenesis.

[16]  G. Kelloff,et al.  Inhibition by dietary oltipraz of experimental intestinal carcinogenesis induced by azoxymethane in male F344 rats. , 1991, Carcinogenesis.

[17]  T. P. Pretlow,et al.  Aberrant crypts: putative preneoplastic foci in human colonic mucosa. , 1991, Cancer research.

[18]  A. Shamsuddin,et al.  Dose-dependent inhibition of large intestinal cancer by inositol hexaphosphate in F344 rats. , 1990, Carcinogenesis.

[19]  S. Minkin,et al.  Promotion of colonic microadenoma growth in mice and rats fed cooked sugar or cooked casein and fat. , 1990, Cancer research.

[20]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[21]  W. R. Bruce,et al.  Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. , 1989, Cancer research.

[22]  R. Bird,et al.  Specificity study to evaluate induction of aberrant crypts in murine colons. , 1988, Cancer research.

[23]  R. Bird,et al.  Aberrant crypts: potential preneoplastic lesions in the murine colon. , 1988, Cancer research.

[24]  R P Bird,et al.  Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. , 1987, Cancer letters.

[25]  M. Tatematsu,et al.  Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver. , 1983, Cancer research.

[26]  T. C. Richards.  Early changes in the dynamics of crypt cell populations in mouse colon following administration of 1,2-dimethylhydrazine. , 1977, Cancer research.

[27]  S. Schwartz,et al.  The identification of monoclonality in human aberrant crypt foci. , 1999, Cancer research.

[28]  T. P. Pretlow,et al.  Aberrant crypts in human colonic mucosa: Putative preneoplastic lesions , 1992, Journal of cellular biochemistry. Supplement.

[29]  T. P. Pretlow,et al.  Colonic aberrant crypts in azoxymethane-treated F344 rats have decreased hexosaminidase activity. , 1990, The American journal of pathology.